JP Morgan Maintains Neutral on LifeStance Health Gr, Raises Price Target to $15
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice Target
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
JP Morgan analyst Lisa Gill maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $13 to $15.
JP Morgan analyst Lisa Gill maintains LifeStance Health Gr (NASDAQ:LFST) with a Neutral and raises the price target from $13 to $15.
